Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07357467Not Yet Recruiting

Effect of Oral Supplement on Influenza Vaccine Long-term Response

Role: collaborator

NCT06827873Not ApplicableNot Yet Recruiting

Effect of Oral Supplements for Influenza Vaccine Response

Role: collaborator

NCT06742450Not ApplicableRecruiting

Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

Role: collaborator

NCT04126382Phase 2Unknown

LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants

Role: collaborator

All 4 trials loaded